PhD, Mathematics, Applied (Operations Research)
MSc, Mathematics, Applied
University of Maryland at College Park, College Park, MD
BSc, Mathematics
Davidson College, Davidson, NC
Will Herring, PhD, is an Executive Director in the Health Economics group at RTI-HS with a background in mathematical modeling and decision analysis across the healthcare system. Over more than a decade with RTI-HS, Dr. Herring has developed an expertise in cost-effectiveness and value-based pricing modeling, and his research been used to inform strategic decisions during the development of new health technologies and to support submissions to healthcare payers and regulatory agencies. His primary research focus is economic modeling for chronic progressive diseases (Alzheimer's disease, chronic liver disease, multiple sclerosis, pulmonary fibrosis, sickle cell disease, transthyretin amyloidosis), with a special interest in the use of patient-level simulation methods for these conditions. Dr. Herring has presented his research on economic modeling and value assessment challenges for AD in multiple national and international settings and is a member of the steering committee for the International Pharmaco-Economic Collaboration for Alzheimer’s Disease (IPECAD) Modelling Group. His experience extends to a range of other therapeutic areas, including vaccines (herpes zoster, respiratory syncytial virus, COVID-19), respiratory (asthma, chronic obstructive pulmonary disease), ophthalmology (diabetic retinopathy, age-related macular degeneration), and dermatology (atopic dermatitis, psoriasis). He is Affiliated to Research at the Karolinska Institutet and is a member of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and the ISPOR Open-Source Models Special Interest Group. His research has been published in peer-reviewed journals, including Pharmacoeconomics, Value in Health, Journal of Internal Medicine, Journal of Managed Care and Specialty Pharmacy, Alzheimer's and Dementia, and Vaccine.